Irish medtech start-up EpiCapture, which has developed a test for the early detection of prostate cancer, is in line for funding of up to €1.5 million after it made the finals of the EIT Health Wild Card competition.
“Having spent time with prostate cancer patients, it became clear that many have an aversion to biopsies which they find to be too invasive. At EpiCapture we place patient experience at the centre of our product development. Our simple urine test will enable more accurate risk-stratification of prostate cancers which will have economic benefits for healthcare systems and quality of life benefits for men with indolent disease,” said Dr Perry, chief executive at EpiCapture.
As part of the competition, teams receive expert mentoring, access to a European health network, and potential funding of up to €1.5 million for the winners. EpiCapture is one of four cancer detection start-ups and four mental health enterprises that have made the final list.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NewstalkFM - 🏆 19. / 55 Read more »